Walter & Keenan Wealth Management’s GSK GSK Stock Holding History

Walter & Keenan Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,120	Closed	-$208K	–	176
2018 Q2	$208K	Buy	+4,120	New	+$208K	0.09%	163
2016 Q3	–	Sell	-4,320	Closed	-$234K	–	144
2016 Q2	$234K	Buy	4,320 +320	+8%	+$16.9K	0.13%	122
2016 Q1	$203K	Sell	4,000 -720	-15%	-$35.9K	0.12%	128
2015 Q4	$238K	Hold	4,720	–	–	0.14%	123
2015 Q3	$227K	Hold	4,720	–	–	0.14%	120
2015 Q2	$246K	Sell	4,720 -20,000	-81%	-$1.13M	0.14%	122
2015 Q1	$1.43M	Hold	24,720	–	–	0.81%	46
2014 Q4	$1.32M	Buy	24,720 +4,800	+24%	+$269K	0.75%	48
2014 Q3	$1.15M	Buy	19,920 +16,000	+408%	+$981K	0.67%	51
2014 Q2	$262K	Hold	3,920	–	–	0.14%	121
2014 Q1	$262K	Buy	+3,920	New	+$265K	0.14%	115

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walter & Keenan Wealth Management's GSK Position: Q3 2018 in Review

Walter & Keenan Wealth Management sold out of GSK (GSK) in Q3 2018, closing a stake of 4,120 shares — an estimated $208K sold.

Walter & Keenan Wealth Management first reported a position in GSK in Q1 2014 and held it in 11 quarters. The position peaked at $1.43M in Q1 2015. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Walter & Keenan Wealth Management reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
Walter & Keenan Wealth Management sold 4,120 GSK shares in Q3 2018, an estimated $208K.
Walter & Keenan Wealth Management first reported a position in GSK in Q1 2014 and held it in 11 quarters.
Walter & Keenan Wealth Management's GSK position peaked at $1.43M in Q1 2015.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Walter & Keenan Wealth Management's 13F filing for Q3 2018, filed 29 Oct 2018.